Human Insulin Market 2022 | Size, Share, Growth | Novo Nordisk A/S, Sanofi S.A, Biocon Ltd, julphar, SemBioSys

The global human insulin market was pegged at ~ US$ 42.5 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030.

The rising prevalence of diabetes is the primary driver of the human insulin market expansion. Because of changes in lifestyle and dietary habits, the percentage of the population suffering from obesity and diabetes has increased significantly. As a result, the demand for human insulin is increasing. For instance, according to the International Diabetic Federation (IDF), nearly 463 million adults aged 20 to 79 years were diagnosed with diabetes in 2019. Furthermore, the figure is expected to rise to around 700 million by 2045. Insulin production technology has advanced significantly, which is increasing its adoption rate. To meet the enormous demand, newer technologies such as recombinant DNA technology have enabled the mass production of insulin.

The rising prevalence of type I diabetes, particularly in North America and emerging Asia Pacific markets, is expected to be the primary market driver. Diabetes prevalence has increased due to an increase in sedentary lifestyles in the United States and some Asia Pacific countries. People's rising incomes are also a major contributor to the rising demand for insulin. Furthermore, rising disease awareness and acceptance are fueling the expansion of the human insulin market.

Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/dental-implants-market/7757

Key Players Mentioned in the Global Human Insulin Market:

• Novo Nordisk A/S
• Sanofi S.A
• Eli Lilly and Company
• Biocon Ltd
• GlaxoSmithCline
• julphar
• SemBioSys
• Wockhardt Limited
• Astra Zeneca PLC
• Tonghua Dongbao Pharmaceutical
• Pfizer Inc
• Merck & Co

Human Insulin Market Segmentation by Drugs:

• Biosimilars
• Biologics

By Applications:

• Type I Diabetes
• Type II Diabetes

Key Reasons to Purchase:

(1) To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

(2) Assess the production processes, major issues, and solutions to mitigate the development risk.

(3) To understand the most affecting driving and restraining forces in the Human Insulin Market and its impact in the global market.

(4) Learn about the market strategies that are being adopted by leading respective organizations.

(5) To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Human Insulin Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Human Insulin Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

Detailed TOC of Global Human Insulin Market Growth (Status and Outlook) 2022-2030

1 Scope of the Report

1.1 Market Ecosystem
1.2 Geographic Scope
1.3 Timeline Under Consideration
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Human Insulin Market Executive Summary

2.1 World Market Overview
2.1.1 Global Market Size 2022-2030
2.1.2 Market Size CAGR by Region 2020 VS 2028
2.2 Human Insulin Market Segment by Type
2.2.1 Type 1
2.2.2 Type 2

Browse the full report now: https://growthplusreports.com/report/human-insulin-market/7723

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.